Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
2 days ago • Google News
Novavax Inc (NVAX)
US$ 6.7050.52%
Price Chart
Key Statistics
Market Cap
$ 965.34M
P/E Ratio
2.17
Revenue (TTM)
$ 1.25B
Volume
5.45M
52W High
$ 23.86
52W Low
$ 5.01
Dividend Yield
0.00%
Beta
3.21
Technicals
50-Day MA
6.851
200-Day MA
9.3289
52 Week High
23.8599
52 Week Low
5.01
About NVAX
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internatio.
Employees
952
Headquarters
Gaithersburg, MD
CEO
Mr. John Charles Jacobs M.B.A.
Latest News
Novavax (NVAX) Awaits New FDA Vaccine Regulatory Framework - GuruFocus
4 hours ago • Google News
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights - PR Newswire
1 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg